News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
180 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28061)
Month
January (2488)
February (2603)
March (3227)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Policy
AXIM Biotech Announces Successful Completion of Pre-IND Meeting With FDA on Comparable Product to Marinol; Green Light From FDA for IND Submission
AXIM will now begin preparing its IND filing to the FDA for this new chewing gum product.
December 12, 2017
·
3 min read
ProImmune Introduces MutaMap High-Throughput Service for Mutational Activity Maps of Therapeutic Proteins
MutaMap provides a high-throughput service, with high-quality output data, to help decide which individual point mutations to pursue and enable better protein engineering decisions to be made, prior to committing a drug candidate to a clinical program.
December 12, 2017
·
2 min read
Business
Rockwell Medical Signs Exclusive License Agreement With Quimica Europea to Commercialize Triferic in Peru
Triferic is the only FDA approved therapy to replace iron and maintain hemoglobin in hemodialysis patients suffering from anemia.
December 12, 2017
·
6 min read
Business
BioGenes Establishes Scientific Advisory Board
BioGenes today announces the establishment of a Scientific Advisory Board which includes the four renowned experts.
December 12, 2017
·
3 min read
Business
UroGen Pharma Expands Clinical Development Leadership Team
In addition, the Company announced the appointment of Elyse Seltzer, M.D., as UroGen’s Senior Vice President of Clinical Development.
December 12, 2017
·
5 min read
Business
Microbiome MDx Specialist Genetic Analysis Signs Supply & Distribution Agreement With Bio-Rad for GA-Map
Genetic Analysis and Bio-Rad today announced that they have signed a supply and distribution agreement for Genetic Analysis’s GA-map clinical test for gut dysbiosis.
December 12, 2017
·
2 min read
Pharm Country
Alumnus Glen de Vries Gives $10M to Endow Carnegie Mellon Deanship, Support Strategic Initiatives in the Sciences
The Glen de Vries Dean’s Chair will first be awarded to MCS Dean Rebecca W. Doerge.
December 12, 2017
·
2 min read
Drug Development
Plitidepsin (PharmaMar) Shows Activity Against the Cells Responsible for the Destruction of Bone in Myeloma Multiple
PharmaMar presented new preclinical data on plitidepsin showing how it regulates the viability and function of bone cells in combination with other anti-multiple myeloma drugs.
December 12, 2017
·
4 min read
Drug Development
AXON Meets the First Milestone in an nfvPPA Phase I Study With AADvac1
The data obtained from the initial 18-week period which assess a high dose of the active vaccine administered for the first time show no safety concerns and allow continuation of the recruitment.
December 12, 2017
·
3 min read
Business
Aldevron to Provide New GMP Cas9 Nuclease Through Agreement With Integrated DNA Technologies
Aldevron and DNA Technologies. Inc. announced a license agreement whereby Aldevron will manufacture and distribute a S. pyogenes Cas9 variant—known as SpyFi Cas9 Nuclease—which is patented by IDT.
December 12, 2017
·
3 min read
Previous
8 of 18
Next